GLSI
Greenwich LifeSciences Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$26.74
+0.20 ▲ +0.75%
🌙 3월 13일 7:32 PM ET (한국 3/14 08:32)
$27.10
+0.36 ▲ +1.34%
| Index | RUT | P/E | - | EPS (ttm) | -1.46 | Insider Own | 52.61% | Shs Outstand | 0.01B | Perf Week | 15.81% |
| Market Cap | 0.37B | Forward P/E | - | EPS next Y | - | Insider Trans | 0.46% | Shs Float | 0.01B | Perf Month | -3.57% |
| Enterprise Value | 0.37B | PEG | - | EPS next Q | -0.33 | Inst Own | 10.47% | Short Float | 20.36% | Perf Quarter | 164.49% |
| Income | -0.02B | P/S | - | EPS this Y | -9.8% | Inst Trans | 5.54% | Short Ratio | 2.35 | Perf Half Y | 134.15% |
| Sales | 0.00B | P/B | 168.82 | EPS next 5Y | - | ROA | -404.39% | Short Interest | 1.34M | Perf YTD | 27.27% |
| Book/sh | 0.16 | P/C | 97.24 | EPS past 3/5Y | -50.9% -32.98% | ROE | -543.43% | 52W High | -21.58% ($34.10) | Perf Year | 126.99% |
| Cash/sh | 0.28 | P/FCF | - | Sales past 3/5Y | - | ROIC | -891.35% | 52W Low | 243.7% ($7.78) | Perf 3Y | 104.28% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -80.51% | Gross Margin | - | Volatility(W/M) | 8.98% 9.21% | Perf 5Y | -8.17% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 2.52 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.35 | EPS Q/Q | -49.88% | Profit Margin | - | RSI (14) | 52.41 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.35 | Sales Q/Q | - | SMA20 | 3.43% ($25.85) | Beta | 1.5 | Target Price | $47.5 |
| Payout | - | Debt/Eq | 0 | Earnings | 2026/02/25 | SMA50 | 2.29% ($26.14) | Rel Volume | 0.28 | Prev Close | $26.54 |
| Employees | 8 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | 84.65% ($14.48) | Avg Volume(3M) | 0.57M | Price | $26.74 |
| IPO | 2020/9/25 | Option/Short | No/Yes | Trades | 1556 | Volume | 160,421 | Change | 0.75% |
뉴스 로딩 중...